Loading institutional data...
Loading institutional data...
Held by 368 of 5,944 reporting institutions (95th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
1/5 of the 9 checks — 4 couldn't be scored (see above), so the score is out of the 5 with data.
Insufficient balance-sheet detail (needs retained earnings, working capital, equity).
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -36%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $57M covers the $3M due within a year 19.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2024-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~6.3% on $1.7B of debt.
Cash of $57M is below short-term debt of $956M — relies on refinancing/operations.
Mostly short-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $1.02B 100.0% | $981.0M 100.0% | $975.0M 100.0% | $988.0M 100.0% | $51.0M 100.0% | $15.0M 100.0% | $22.3M 100.0% | $13.1M 100.0% | $30.6M 100.0% |
| Research & Development | — | — | — | — | — | — | — | $6.0M 26.8% | $8.2M 62.3% | $10.2M 33.5% |
| Selling, General & Admin | — | $432.0M 42.5% | $399.0M 40.7% | $395.0M 40.5% | $442.0M 44.7% | $76.0M 149.0% | $33.0M 220.0% | $23.5M 105.6% | $24.1M 183.8% | $34.7M 113.5% |
| Total Operating Expenses | — | $924.0M 90.9% | $908.0M 92.6% | $1.01B 104.0% | $1.09B 109.9% | $111.0M 217.6% | $44.0M 293.3% | $2.0M 9.2% | $2.6M 19.7% | $2.8M 9.1% |
| Operating Income | -$36.0M | -$50.0M -4.9% | -$39.0M -4.0% | -$39.0M -4.0% | -$98.0M -9.9% | -$60.0M -117.6% | -$29.0M -193.3% | -$12.0M -54.0% | -$25.5M -194.6% | -$21.2M -69.2% |
| Interest Expense | $110.0M | $145.0M 14.3% | $206.0M 21.0% | $133.0M 13.6% | $117.0M 11.8% | $28.0M 54.9% | $25.0M 166.7% | $23.3M 104.7% | $19.6M 149.5% | $15.0M 48.9% |
| Other Income (Expense), net | -$1.0M | $12.0M 1.2% | $23.0M 2.3% | -$70.0M -7.2% | -$6.0M -0.6% | $3.0M 5.9% | $1.0M 6.7% | $963K 4.3% | $1.4M 10.9% | $336K 1.1% |
| Pretax Income | -$3.25B | $983.0M 96.8% | $823.0M 83.9% | $1.53B 157.3% | $950.0M 96.2% | $361.0M 707.8% | $155.0M 1033.3% | $91.9M 412.8% | $2.45B 18718.3% | $1.48B 4824.7% |
| Income Tax Expense | -$923.0M | $187.0M 18.4% | $175.0M 17.8% | $277.0M 28.4% | $218.0M 22.1% | -$37.0M -72.5% | $38.0M 253.3% | $21.9M 98.5% | $416.9M 3184.6% | $558.4M 1825.6% |
| Net Income | -$2.68B | $869.0M 85.5% | $688.0M 70.1% | $1.26B 128.9% | $732.0M 74.1% | $398.0M 780.4% | $117.0M 780.0% | $70.0M 314.3% | $2.03B 15533.7% | $917.3M 2999.1% |
| Per Share | ||||||||||
| EPS (Basic) | — | $6.08 | $4.71 | $8.01 | $3.97 | $2.18 | $0.65 | $0.39 | $11.19 | $6.03 |
| EPS (Diluted) | — | $6.08 | $4.68 | $7.96 | $3.93 | $2.17 | $0.64 | $0.38 | $11.10 | $6.00 |
| Weighted Avg Shares (Basic) | 143.0M | 143.0M | 146.0M | 157.0M | 185.0M | 182.0M | 181.5M | 181.3M | 181.8M | 152.1M |
| Weighted Avg Shares (Diluted) | 143.0M | 143.0M | 147.0M | 158.0M | 186.0M | 183.0M | 182.8M | 182.6M | 183.1M | 152.9M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
No current price collected.
No standout strengths flagged.
Nothing notable to watch.
Where each multiple sits in its own 12-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 12-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Operating leverage needs meaningful revenue change.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| R&D | 26.8 | — | — | — | — | — | — | — |
| SG&A | 105.6 | 220.0 | 149.0 | 44.7 | 40.5 | 40.7 | 42.5 | — |
| Operating Income | -54.0 | -193.3 | -117.6 | -9.9 | -4.0 | -4.0 | -4.9 | — |
| Income Tax | 98.5 | 253.3 | -72.5 | 22.1 | 28.4 | 17.8 | 18.4 | — |
| Net Income | 314.3 | 780.0 | 780.4 | 74.1 | 128.9 | 70.1 | 85.5 | — |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on LBRDK: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.